1. On February 1, 2019, the Company entered into an agreement for the sale of 2,751,200 ADO shares, constituting 10%
Biopharmaceuticals Contract Manufacturing Market Worth $21.7 Billion by 2025: Grand View Research, Inc.
Generex Biotechnology Signs Clinical Trial Agreement With the NSABP Foundation, Inc. for Phase II Clinical Trial of AE37 in Combination With Pembrolizumab (Keytruda®) for Treatment of Triple-Negative Breast Cancer
FinancialBuzz.com News Commentary ‘Futures had been drifting higher this morning [Thursday], but a ton of economic data was just released
NetCents Technology Eliminates Blockchain Transaction Delays With Zero Confirmation and Risk Analysis
Worldpay and Sage Partner to Provide Fast and Efficient Payments to Businesses Across the UK and Ireland
Check out technology changing the life.
LIMASSOL, Cyprus, Feb. 8, 2019 WhichBingo revealed details of their annual online report at the 2019 London Affiliate Conference. The